Clinical trial
Real-world Treatment Patterns and Clinical Outcomes in Epidermal Growth Factor Receptor(EGFR)-Mutant Unresectable Locally Advanced NSCLC: A Retrospective Multi-center Study
NCT04304638 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Treatment Patterns and Clinical Outcomes in Epidermal Growth Factor Receptor(EGFR)-Mutant Unresectable Locally Advanced NSCLC: A Retrospective Multi-center Study
- Lead sponsor
- Chinese Academy of Medical Sciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2020
- Completion date
- June 30, 2020
- Enrollment
- 450 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
egfr mutation-related tumors, non small cell lung cancer, stage iii non-small-cell lung cancer